Search Within

Computational Oncology Service

  1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (20)
  3. Review (1)
Groups
  1. Department of Medicine (44)
  2. Epidemiology and Biostatistics (44)
  3. GSK Faculty (44)
  4. Melanoma and Immunotherapeutics Service (44)
  5. Solid Tumor Oncology Division (44)
  6. Human Oncology and Pathogenesis Program (35)

More Groups

People
  1. Nikolaus Schultz (23)
  2. Jedd Wolchok (19)
  3. Taha Merghoub (19)
  4. David Solit (17)
  5. Alexander Shoushtari (15)
  6. Francisco Sanchez Vega (12)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (12)
  5. 2021 (4)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (4)
  3. Nature (4)
  4. Cancer Cell (3)
  5. Clinical Cancer Research (3)
  6. Journal for ImmunoTherapy of Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (7)
  3. Nature Publishing Group (6)
  4. Cell Press (5)
  5. Biomed Central Ltd (3)
  6. Nature Research (3)

More Publishers

Results (44)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • COVID-19 in patients with lung cancers in New York City
    Meeting Abstract

    Luo, J.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Hoyos, D.; Bandlamudi, C.; Donoghue, M. T. A.; Łuksza, M.; Greenbaum, B. D.; Wolchok, J. D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Leveraging systematic functional analysis to benchmark an in silico framework distinguishes driver from passenger MEK mutants in cancer
    Journal Article

    Hanrahan, A. J.; Sylvester, B. E.; Chang, M. T.; Elzein, A.; Gao, J.; Han, W.; Liu, Y.; Xu, D.; Gao, S. P.; Gorelick, A. N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma
    Journal Article

    Yang, C.; Sanchez-Vega, F.; Chang, J. C.; Chatila, W. K.; Shoushtari, A. N.; Ladanyi, M.; Travis, W. D.; Busam, K. J.; Rekhtman, N.
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • UV genomic signature classifies lung melanomas of unknown primary as metastases from occult cutaneous melanomas
    Meeting Abstract

    Yang, C.; Sanchez-Vega, F.; Shoushtari, A.; Ladanyi, M.; Travis, W.; Busam, K.; Rekhtman, N.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Krieger, P.; Sanchez-Vega, F.; Schultz, N.; Shoushtari, A.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save